 Hoth Therapeutics Inc NASDAQ: HOTH shares are trading higher by 125.5 at 1.38 after the company said its mRNA frame-shifting therapeutic proved effective against aggressive cancer cells. Hoth says treatment with HT-KIT prevented cancer cell growth and induced death in neoplastic mast cells. 